4-nitrophthalimide has been researched along with Hyperuricemia in 1 studies
*Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| B-Rao, C; Bahirat, U; Brahma, MK; Deshmukh, NJ; Dixit, A; Doshi, L; Ghosh, U; Katkar, KV; Keche, A; Khanna, S; Korde, V; Kulkarni-Almeida, A; Nemmani, KV; Shah, P; Sharma, R; Sivaramakrishnan, H; Srivastava, A | 1 |
1 other study(ies) available for 4-nitrophthalimide and Hyperuricemia
| Article | Year |
|---|---|
Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits.
Topics: Animals; Computer Simulation; Cytosine; Enzyme Activation; Enzyme Inhibitors; Hyperuricemia; Male; Oxonic Acid; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Xanthine Oxidase | 2012 |